{
  "catalogId": "ee1ad3d1-2051-454f-b049-8bbc873d0544",
  "name": "DOVATO",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "165 26 36147 00",
  "treatmentDescriptions": "Dovato is indicated for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg, with no known or suspected resistance to the integrase inhibitor class, or lamivudine and viral load ≤500,000 c/mL.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "LAMIVUDINE, DOLUTEGRAVIR AS SODIUM",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "J05AR25",
      "name": "LAMIVUDINE AND DOLUTEGRAVIR"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "DOVATO 50 MG/ 300 MG 30 TAB",
      "manufacturer": {
        "name": "ג.ס.ק",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BOTTLE HDPE",
      "shelfLife": "48",
      "storageConditions": "",
      "codes": {
        "moh": "8505",
        "yarpa": "60960",
        "pharmasoft": "4723",
        "barcode": "7290014547612"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 2280.733055,
        "retailMargin": 10.0,
        "maxRetailPrice": 2508.80636,
        "maxPriceWithVAT": 2960.391373
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:44.347675"
  }
}